According to the latest report by IMARC Group, titled “Vietnam Insulin Drug and Delivery Device Market Report by Type (Insulin Drugs, Insulin Device), and Region 2024-2032,” finds that the Vietnam insulin drug and delivery device market is expected to exhibit a CAGR of 1.98% during the forecast period (2024-2032). Insulin drugs and delivery devices are used to manage diabetes, which is a chronic medical condition characterized by high levels of blood sugar. They can reduce the risks of diabetes-related complications, such as cardiovascular issues, vision impairment, foot ulcers, kidney problems, and nerve damage. They enable individuals with diabetes to lead a more normal and active life and assist in improving their overall quality of life. They aid in maintaining stable blood sugar levels among patients undergoing surgeries in hospitals. They are beneficial in providing a continuous low-level release of insulin to mimic the insulin needs of the body. As they minimize the risks associated with incorrect dosing, the demand for insulin drugs and delivery devices is increasing in Vietnam.
Vietnam Insulin Drug and Delivery Device Market Trends:
The rising adoption of safe and reliable insulin drugs and delivery devices among the geriatric population currently represents one of the key factors bolstering the market growth in Vietnam. Moreover, the increasing awareness about diabetes and the importance of timely treatment among people is strengthening the market growth in the country. In line with this, the escalating demand for insulin drugs and delivery devices on account of the rising prevalence of diabetes among the masses in Vietnam is positively influencing the market. Furthermore, advancements in insulin delivery device technology, such as smart insulin pens and wearable pumps, assist in improving patient outcomes, which is supporting the market growth. Apart from this, the increasing focus on patient-centric treatment approaches is impelling the growth of the market in Vietnam. In addition, the growing demand for insulin pens, as they are user-friendly, provide precise dosing, and can be self-administered, along with the rising adoption of convenient and cost-effective insulin delivery devices among patients, is offering a favorable market outlook in the country. Besides this, the increasing employment of insulin drugs and delivery devices to lower the chances of complications and provide enhanced outcomes for patients is propelling the market growth in Vietnam.
Market Summary:
- Based on the type, the market has been bifurcated into insulin drugs (basal or long acting insulins, bolus or fast acting insulins, traditional human insulins, biosimilar insulins, and insulin combinations) and insulin device (insulin pumps, insulin pens, insulin syringes, and insulin jet injectors).
- Region-wise, the market has been segmented into Northern, Central, and Southern Vietnam.
- The competitive landscape of the market has been examined in the report, along with the detailed profiles of the major players operating in the industry.
Report Scope:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Types Covered |
- Insulin Drugs: Basal or Long Acting Insulins, Bolus or Fast Acting Insulins, Traditional Human Insulins, Biosimilar Insulins, Insulin Combinations
- Insulin Device: Insulin Pumps, Insulin Pens, Insulin Syringes, Insulin Jet Injectors
|
Regions Covered |
Northern Vietnam, Central Vietnam, Southern Vietnam |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800